SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-23-005916
Filing Date
2023-06-30
Accepted
2023-06-30 16:56:17
Documents
16

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2677873
2 filename2.htm EX-3.1 126119
3 filename3.htm EX-3.3 163806
4 filename4.htm EX-10.1 221054
5 filename5.htm EX-10.7(A) 83213
6 filename6.htm EX-10.7(B) 54408
7 filename7.htm EX-10.7(C) 69681
8 filename8.htm EX-10.10 63025
9 filename9.htm EX-10.11 64795
10 filename10.htm EX-10.12 63452
11 GRAPHIC g241143g29z30.jpg GRAPHIC 218439
12 GRAPHIC g241143g33a33.jpg GRAPHIC 125995
13 GRAPHIC g241143g37a37.jpg GRAPHIC 107358
14 GRAPHIC g241143g51j79.jpg GRAPHIC 73986
15 GRAPHIC g241143g62u59.jpg GRAPHIC 188378
16 GRAPHIC g241143g86c02.jpg GRAPHIC 37470
  Complete submission text file 0000950123-23-005916.txt   4624820
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-05663 | Film No.: 231062495
SIC: 2836 Biological Products, (No Diagnostic Substances)